SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Sumitomo Chemical Company, Limited (SOMMY) trades at a trailing P/E of 0.1, forward P/E of 0.1. Trailing earnings yield is 714.29%, forward earnings yield 909.09%.
Criteria proven by this page:
- VALUE (100/100, Pass) — P/E is below market average (0.1); earnings yield beats bond yields (714.29%).
- Forward P/E 0.1 (down from trailing 0.1) — analysts expect earnings to grow, which would improve the valuation.
- Trailing Earnings Yield 714.29% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income. Forward yield improves to 909.09% as earnings recover.
Overall SharesGrow Score: 55/100 with 1/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — SOMMY
Valuation Multiples
P/E (TTM)0.1
Forward P/E0.1
PEG RatioN/A
Forward PEG0.00
P/B Ratio0.00
P/S Ratio0.00
EV/EBITDA0.0
Per Share Data
EPS (TTM)$117.90
Forward EPS (Est.)$145.59
Book Value / Share$0.00
Revenue / Share$7,962.90
FCF / Share$0.00
Yields & Fair Value
Earnings Yield714.29%
Forward Earnings Yield909.09%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2015 |
$1,244.50 |
$2.1T |
$81.45B |
3.9% |
| 2016 |
$1,169.25 |
$1.95T |
$76.54B |
3.9% |
| 2017 |
$2,045.25 |
$2.19T |
$133.77B |
6.1% |
| 2018 |
$1,804.13 |
$2.32T |
$117.99B |
5.1% |
| 2019 |
$94.57 |
$2.23T |
$30.93B |
1.4% |
| 2020 |
$94.60 |
$2.23T |
$30.93B |
1.4% |
| 2021 |
$140.80 |
$2.29T |
$46.04B |
2% |
| 2022 |
$21.35 |
$2.9T |
$6.99B |
0.2% |
| 2023 |
$-953.45 |
$2.45T |
$-311.84B |
-12.7% |
| 2025 |
$117.90 |
$2.61T |
$38.59B |
1.5% |
